Recently, according to China's National Health Commission’s administrative licensing information system, D-allulose has been added to the Terminated Review List of New Food Raw Materials.
This product is produced using fructose as the raw material, which is converted by D-allulose-3-epimerase catalysis followed by multiple processing steps. As it is considered substantially equivalent to the already approved D-allulose, the review process has been terminated.
Review Comments
This product is manufactured using fructose as the raw material and converted through catalysis by the permitted D-psicose 3-epimerase (NHC Announcement No. 1 of 2026; derived from Bacillussubtilis, with the donor strain Agrobacteriumtumefaciens C58), followed by decolorization, separation, purification, crystallization, drying, and other processing steps. It is considered substantially equivalent to the D-allulose approved as a new food ingredient under NHC Announcement No. 4 of 2025, and therefore, the review has been terminated. Except for the source of the D-psicose 3-epimerase, all other requirements shall comply with the relevant provisions already announced for D-allulose.
About CIRS Food Division
Established in 2012, the Food Business Division of CIRS Group has helped over 1,000 food companies globally in achieving one-stop compliance solutions. CIRS offers a full range of regulatory services, including but not limited to China novel food applications, synthetic biology-derived foods, U.S. GRAS notices, EU novel food applications, health food registration, and food for special medical purposes (FSMP).
If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.
